Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by Nathalie Bonnefoy
Group name EquipeNB
Item Type Journal Article
Title Immune signatures of protective spleen memory CD8 T cells
Creator Brinza et al.
Author L. Brinza
Author S. Djebali
Author M. Tomkowiak
Author J. Mafille
Author C. Loiseau
Author P. E. Jouve
Author S. de Bernard
Author L. Buffat
Author B. Lina
Author M. Ottmann
Author M. Rosa-Calatrava
Author S. Schicklin
Author N. Bonnefoy
Author G. Lauvau
Author M. Grau
Author M. Wencker
Author C. Arpin
Author T. Walzer
Author Y. Leverrier
Author J. Marvel
Abstract Memory CD8 T lymphocyte populations are remarkably heterogeneous and differ in their ability to protect the host. In order to identify the whole range of qualities uniquely associated with protective memory cells we compared the gene expression signatures of two qualities of memory CD8 T cells sharing the same antigenic-specificity: protective (Influenza-induced, Flu-TM) and non-protective (peptide-induced, TIM) spleen memory CD8 T cells. Although Flu-TM and TIM express classical phenotypic memory markers and are polyfunctional, only Flu-TM protects against a lethal viral challenge. Protective memory CD8 T cells express a unique set of genes involved in migration and survival that correlate with their unique capacity to rapidly migrate within the infected lung parenchyma in response to influenza infection. We also enlighten a new set of poised genes expressed by protective cells that is strongly enriched in cytokines and chemokines such as Ccl1, Ccl9 and Gm-csf. CCL1 and GM-CSF genes are also poised in human memory CD8 T cells. These immune signatures are also induced by two other pathogens (vaccinia virus and Listeria monocytogenes). The immune signatures associated with immune protection were identified on circulating cells, i.e. those that are easily accessible for immuno-monitoring and could help predict vaccines efficacy.
Publication Sci Rep
Volume 6
Pages 37651
Date Nov 24 2016
Journal Abbr Scientific reports
DOI 10.1038/srep37651
ISSN 2045-2322 (Electronic) 2045-2322 (Linking)
Tags original
Date Added 2018/11/14 - 12:04:32
Date Modified 2019/05/28 - 21:22:35
Notes and Attachments (Note)
(Note)
27883012 (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés